0001543053-17-000002.txt : 20170831 0001543053-17-000002.hdr.sgml : 20170831 20170831190443 ACCESSION NUMBER: 0001543053-17-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170830 FILED AS OF DATE: 20170831 DATE AS OF CHANGE: 20170831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harrelson Lori R. CENTRAL INDEX KEY: 0001543053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35443 FILM NUMBER: 171064244 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DRIVE CITY: DURHAM STATE: NC ZIP: 27704 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC CENTRAL INDEX KEY: 0001105533 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562110007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 BUSINESS PHONE: 9192876300 MAIL ADDRESS: STREET 1: 4233 TECHNOLOGY DR CITY: DURHAM STATE: NC ZIP: 27704 FORMER COMPANY: FORMER CONFORMED NAME: MERIX BIOSCIENCE INC DATE OF NAME CHANGE: 20000207 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-08-30 0 0001105533 ARGOS THERAPEUTICS INC ARGS 0001543053 Harrelson Lori R. 4233 TECHNOLOGY DRIVE DURHAM NC 27704 0 1 0 0 Vice President of Finance Common Stock 2017-08-30 4 A 0 320683 0 A 354382 D The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 160,341 shares on January 2, 2018, and with respect to the remaining 160,342 shares on January 9, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date. /s/ Lori R. Harrelson, attorney-in-fact 2017-08-31